237 related articles for article (PubMed ID: 23894121)
1. The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity.
Guo F; Moellering DR; Garvey WT
Obesity (Silver Spring); 2014 Jan; 22(1):110-8. PubMed ID: 23894121
[TBL] [Abstract][Full Text] [Related]
2. APPLICATION OF THE AACE/ACE ADVANCED FRAMEWORK FOR THE DIAGNOSIS OF OBESITY AND CARDIOMETABOLIC DISEASE STAGING IN A GENERAL POPULATION FROM 3 REGIONS OF VENEZUELA: THE VEMSOLS STUDY RESULTS.
Nieto-Martínez R; González-Rivas JP; Ugel E; Brajkovich I; Risquez A; Garvey WT; Mechanick JI
Endocr Pract; 2018 Jan; 24(1):6-13. PubMed ID: 29106817
[TBL] [Abstract][Full Text] [Related]
3. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
[TBL] [Abstract][Full Text] [Related]
4. Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension.
Bergman M; Chetrit A; Roth J; Dankner R
Diabetes Metab Res Rev; 2015 May; 31(4):368-75. PubMed ID: 25352076
[TBL] [Abstract][Full Text] [Related]
5. Association of body mass index and its long-term changes with cardiometabolic diseases: A nationwide twin study.
Guo J; Li X; Yang R; Marseglia A; Dove A; Johnell K; Xu W
Clin Nutr; 2021 Nov; 40(11):5467-5474. PubMed ID: 34656027
[TBL] [Abstract][Full Text] [Related]
6. [Situation of impaired glucose regulation and metabolic syndrome in overweight or obesity adolescent students in Dongguan city].
Peng YQ; Nie WM; Chen JG; Tang HM; Cao T; Lin YX
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jun; 43(6):495-500. PubMed ID: 19950716
[TBL] [Abstract][Full Text] [Related]
7. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.
Unwin N; Shaw J; Zimmet P; Alberti KG
Diabet Med; 2002 Sep; 19(9):708-23. PubMed ID: 12207806
[TBL] [Abstract][Full Text] [Related]
8. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.
Andes LJ; Cheng YJ; Rolka DB; Gregg EW; Imperatore G
JAMA Pediatr; 2020 Feb; 174(2):e194498. PubMed ID: 31790544
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study.
Li Y; Feng D; Esangbedo IC; Zhao Y; Han L; Zhu Y; Fu J; Li G; Wang D; Wang Y; Li M; Gao S; Willi SM
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049638
[TBL] [Abstract][Full Text] [Related]
12. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
[TBL] [Abstract][Full Text] [Related]
13. Clinical and metabolomic predictors of regression to normoglycemia in a population at intermediate cardiometabolic risk.
Sevilla-González MDR; Merino J; Moreno-Macias H; Rojas-Martínez R; Gómez-Velasco DV; Manning AK
Cardiovasc Diabetol; 2021 Feb; 20(1):56. PubMed ID: 33639941
[TBL] [Abstract][Full Text] [Related]
14. Risk of chronic kidney disease in young adults with impaired glucose tolerance/impaired fasting glucose: a retrospective cohort study using electronic primary care records.
Jadhakhan F; Marshall T; Ryan R; Gill P
BMC Nephrol; 2018 Feb; 19(1):42. PubMed ID: 29482513
[TBL] [Abstract][Full Text] [Related]
15. Obesity measures, metabolic health and their association with 15-year all-cause and cardiovascular mortality in the SAMINOR 1 Survey: a population-based cohort study.
Michalsen VL; Wild SH; Kvaløy K; Svartberg J; Melhus M; Broderstad AR
BMC Cardiovasc Disord; 2021 Oct; 21(1):510. PubMed ID: 34674643
[TBL] [Abstract][Full Text] [Related]
16. Relationship between BMI and risk of impaired glucose tolerance and impaired fasting glucose in Chinese adults: a prospective study.
Zhang X; Yue Y; Liu S; Cong X; Wang W; Li J
BMC Public Health; 2023 Jan; 23(1):14. PubMed ID: 36597050
[TBL] [Abstract][Full Text] [Related]
17. Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study.
Pankow JS; Kwan DK; Duncan BB; Schmidt MI; Couper DJ; Golden S; Ballantyne CM
Diabetes Care; 2007 Feb; 30(2):325-31. PubMed ID: 17259502
[TBL] [Abstract][Full Text] [Related]
18. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
[TBL] [Abstract][Full Text] [Related]
19. An Empirically Derived Definition of Metabolically Healthy Obesity Based on Risk of Cardiovascular and Total Mortality.
Zembic A; Eckel N; Stefan N; Baudry J; Schulze MB
JAMA Netw Open; 2021 May; 4(5):e218505. PubMed ID: 33961036
[TBL] [Abstract][Full Text] [Related]
20. [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study].
Chen Y; Wang J; An Y; Gong Q; He Y; Zhang B; Li H; Shuai Y; Tang X; Jiang Y; Hong J; Yang W; Hu Y; Li G
Zhonghua Nei Ke Za Zhi; 2015 Jan; 54(1):13-7. PubMed ID: 25877139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
